Trip.com Group Ltd: Form 20-F for the period ended Dec 31, 2023
Filed with the SEC on Apr 29, 2024 and accepted by EDGAR at Apr 29, 2024, 16:03 ET.
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2023-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 12 months2023-01-01 to 2023-12-31 | $6.27bn | us-gaap:Revenues |
| Cost of revenue | 12 months2023-01-01 to 2023-12-31 | $1.14bn | us-gaap:CostOfRevenue |
| Gross profit | 12 months2023-01-01 to 2023-12-31 | $5.13bn | us-gaap:GrossProfit |
| Research and development | 12 months2023-01-01 to 2023-12-31 | $1.71bn | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 12 months2023-01-01 to 2023-12-31 | $1.59bn | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months2023-01-01 to 2023-12-31 | $291.0m | us-gaap:InterestExpense |
| Income tax | 12 months2023-01-01 to 2023-12-31 | $246.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months2023-01-01 to 2023-12-31 | $1.40bn | us-gaap:NetIncomeLoss |
| Diluted shares (weighted) | 12 months2023-01-01 to 2023-12-31 | 671,062,240 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2023-01-01 to 2023-12-31 | $3.10bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months2023-01-01 to 2023-12-31 | $85.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 12 months2023-01-01 to 2023-12-31 | $228.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2023-12-31 | $5.86bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2023-12-31 | $12.50bn | us-gaap:AssetsCurrent |
| Total assets | At period end2023-12-31 | $30.86bn | us-gaap:Assets |
| Current liabilities | At period end2023-12-31 | $10.20bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2023-12-31 | $13.54bn | us-gaap:Liabilities |
| Long-term debt | At period end2023-12-31 | $2.69bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2023-12-31 | $3.64bn | us-gaap:DebtCurrent |
| Shareholders' equity | At period end2023-12-31 | $17.21bn | us-gaap:StockholdersEquity |
| Shares outstanding | At period end2023-12-31 | 644,089,050 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0001193125-24-122196. Last ingested by Listed: Nov 14, 2026, 14:00 ET. Listed shows no prices and gives no investment advice.